2023-05-01 16:07:55 ET
- OrthoPediatrics press release ( NASDAQ: KIDS ): Q1 Non-GAAP EPS of -$0.29 beats by $0.05 .
- Revenue of $31.59M (+34.9% Y/Y) beats by $2.29M .
- For the full year of 2023, the Company increased its revenue guidance to be in the range of $148.0 million to $151.0 million vs $147.32M consensus, representing growth of 21% to 23% over 2022 revenue. The guidance assumes roughly $7.0 million of combined revenue contribution from MD Ortho and Pega Medical before the acquisitions become organic on their anniversaries. The Company reiterated annual set deployment of approximately $25.0 million and reiterated $3.0 million to $4.0 million of adjusted EBITDA for the full year of 2023.
For further details see:
OrthoPediatrics Non-GAAP EPS of -$0.29 beats by $0.05, revenue of $31.59M beats by $2.29M